Qpex Biopharma

About:

Qpex Biopharma develops a pipeline of agents addressing critical needs for the treatment of infectious diseases.

Website: https://www.qpexbio.com/

Top Investors: Adams Street Partners, New Enterprise Associates, Hatteras Venture Partners, Stanford University, Biomedical Advanced Research and Development Authority (BARDA)

Description:

Qpex Biopharma develops a pipeline of agents addressing critical needs for the treatment of infectious diseases. It develops multiple antibiotic drugs intended to combat antimicrobial resistance. The company's technology is focused on targeting the treatment of infectious diseases for both inpatient and outpatient cases, deep expertise in the discovery, development and regulatory approval of anti-infective medicines, including an extensive record of working with public/private partnerships focused on new antibiotics to combat antimicrobial resistance, enabling medical businesses optimal use of products and critical needs for the treatment of infectious diseases in the inpatient and outpatient settings. It was founded in 2018 and is headquartered in San Diego, California.